Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
In this study, we aimed to establish the technology for the development of next-generation antibody therapeutics by advancing our protein linking method based on the hetero-tetramerization of the peptides. First, we succeeded in preparing the trispecific antibody by imparting different specificity to the previously produced bispecific antibody. Furthermore, we successfully produced the functional bispecific antibody-drug conjugate, indicating that our protein linking method is useful for construction of drug delivery system.
|